课题基金 / 基金详情

Analysis of molecular mechanism in endometrial cancer development.

Analysis of molecular mechanism in endometrial cancer development.
子宫内膜癌发生发展的分子机制分析。
批准号:
12557138
负责人:
KATO Kiyoko
金额:
$8.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

KATO Kiyoko的其他基金

相似基金

相关文献

中文摘要
翻译
我们之前报道过雌激素受体α(ERα)的转录激活增强有助于K-Ras介导的NIH3T3细胞转化[^<12> Val]。在活化的K-Ras 4B突变体存在的情况下,ERα显性负突变体(DNER)使ERα功能失活,使细胞周期阻滞在G0/G1,随后引发复制性细胞衰老,最终消除致瘤潜能。p53依赖性的p21上调与细胞衰老诱导有关。MDM2蛋白对DNER反应的改变解释了p21介导的细胞衰老诱导。一个致癌的K-Ras 4B突变体显著增加MDM2蛋白与p53共沉淀,抑制p53的转录活性。反过来,DNER发挥其功能,减少与p53共沉淀的MDM2蛋白,随后在致癌的K-Ras 4B突变体存在下刺激p53活性。此外,野生型ERα在NIH3T3细胞中过表达,导致MDM2蛋白水平显著升高,进而抑制p53转录活性。最后,我们证明了c-Jun的表达克服了p21蛋白水平在DNER反应中的抑制和增强。这些数据表明,致癌K-Ras 4B突变体激活的ERα-APl通路通过MDM2调节p53的转录活性,从而促进了NIH3T3细胞的转化。
英文摘要
We previously reported that enhanced transcriptional activation of estrogen receptorα(ERα) contributed to [^<12> Val] K-Ras mediated NIH3T3 cell transformation. Functional inactivation of ERα by a dominant negative mutant of ERα (DNER) in the presence of activated K-Ras 4B mutant arrested the cell cycle at G0/G1, subsequently provoking replicative cell senescence, finally abrogating tumorigenic potential. p53-dependent up-regulation of p21 was implicated in this cell senescence induction. Alterations in the MDM2 protein in response to DNER accounted for this p21-mediated cell senescence induction. An oncogenic K-Ras 4B mutant significantly increased MDM2 proteins coprecipitated with p53, and suppressed p53 transcriptional activity. In turn, DNER exerted its function to decrease MDM2 proteins coprecipitated with p53, followed by the stimulation of p53 activity in the presence of the oncogenic K-Ras 4B mutant. In addition, overexpression of wild type ERα in NIH3T3 cells resulted in the significant increase in the MDM2 protein level and the resultant suppression of p53 transcriptional activity. Finally, we demonstrated that c-Jun expression overcame the suppression and resultant enhancement of p21 protein level in response to DNER. The data imply that the ERα-APl pathway activated by oncogenic K-Ras 4B mutant contributes to the NIH3T3 cells' transformation by modulating p53 transcriptional activity through MDM2.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Kato H et al.: "Growth-associated Gene Expression Profiles by Microarray Analysis of Trophoblast of Molar Pregnancies and Normal Villi"International Journal of Gynecological Pathology. 21,3. 255-260 (2002)
Kato H 等人:“通过微阵列分析葡萄胎妊娠和正常绒毛滋养层的生长相关基因表达谱”国际妇科病理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato K et al.: "Contribution of estrogen receptora (ERα) to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway"J.Biol.Chem. 277,13. 11217-11224 (2002)
Kato K 等人:“雌激素受体α (ERα) 对致癌 K-Ras 介导的 NIH3T3 细胞转化的贡献及其通过调节 p53 途径逃避衰老的意义”J.Biol.Chem. 11217-11224。 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueoka Y et al: "Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras mediated pathway."Molecular and cellular endocrinology. in press.
Ueoka Y 等人:“肝细胞生长因子通过 Ras 介导的途径调节卵巢癌的运动性和侵袭性。”分子和细胞内分泌学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato K et al.: "Contribution of estrogen receptora (ERα) to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway"J. Biol. Chem. 277,13,. 11217-11224 (2002)
Kato K 等人:“雌激素受体 (ERα) 对 K-Ras 介导的 NIH3T3 细胞转化的贡献及其通过调节 p53 途径逃避衰老的意义”J. Biol。 11224 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
19
    Identification of endometrial cancer stem cell markers
    • 批准号:
      24659736
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2012
    • 负责人:
      KATO Kiyoko
    • 依托单位:
    Development of new target therapy for endometrial cancer stem cells
    Contribution of the genomic diversity to the development and carcinogenesis of endometriosis
    • 批准号:
      22659302
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.96万
    • 财政年份:
      2010
    • 负责人:
      KATO Kiyoko
    • 依托单位:
    Analysis of endometrial cancer development
    • 批准号:
      17390452
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.71万
    • 财政年份:
      2005
    • 负责人:
      KATO Kiyoko
    • 依托单位:
    国内基金
    海外基金
    基于“郁痰”理论探讨海藻消瘤胶囊调控ERα-PPARγ轴抑制PTC细胞代谢失衡的作用机制
    基于MAMs途径调控ER-phagy探讨肾安汤治疗糖尿病肾病的作用机制
    SWI/SNF介导的表观遗传重塑与ER-α36依赖的信号编程协同调控非小细胞肺癌治疗抵抗的机制研究
    • 批准号:
      2026JJ82016
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      龚灿
    • 依托单位:
    CENPI/NRF2/ALDH3A1 信号轴介导的脂质代谢重编程诱导ER阳性乳腺癌免疫抑制的作用机制研究
    • 批准号:
      JCZRLH202600982
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: